Flow Traders U.S.’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Flow Traders U.S.’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,993	Closed	-$217K	–	1036
2023 Q3	$217K	Buy	+2,993	New	+$229K	0.01%	695
2022 Q3	–	Sell	-3,046	Closed	-$228K	–	1183
2022 Q2	$228K	Buy	+3,046	New	+$231K	0.01%	678
2022 Q1	–	Sell	-5,787	Closed	-$469K	–	940
2021 Q4	$469K	Buy	5,787 +1,281	+28%	+$101K	0.03%	493
2021 Q3	$349K	Buy	+4,506	New	+$363K	0.01%	795
2020 Q4	–	Sell	-32,446	Closed	-$2.07M	–	729
2020 Q3	$2.07M	Buy	+32,446	New	+$2.12M	0.15%	134

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Flow Traders U.S.'s PJP Position: Q4 2023 in Review

Flow Traders U.S. sold out of Invesco Pharmaceuticals ETF (PJP) in Q4 2023, closing a stake of 2,993 shares — an estimated $217K sold.

Flow Traders U.S. first reported a position in PJP in Q3 2020 and held it in 5 quarters. The position peaked at $2.07M in Q3 2020. 86 funds tracked by Wall St. Rank hold PJP as of Q4 2023.

Flow Traders U.S. reported no remaining Invesco Pharmaceuticals ETF position as of Q4 2023 after selling out during the quarter.
Flow Traders U.S. sold 2,993 Invesco Pharmaceuticals ETF shares in Q4 2023, an estimated $217K.
Flow Traders U.S. first reported a position in Invesco Pharmaceuticals ETF in Q3 2020 and held it in 5 quarters.
Flow Traders U.S.'s Invesco Pharmaceuticals ETF position peaked at $2.07M in Q3 2020.
86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q4 2023.

Based on Flow Traders U.S.'s 13F filing for Q4 2023, filed 14 Feb 2024.